David Y. Bouffard

Discovery of 4-Aryl-4<i>H</i>-chromenes as a New Series of Apoptosis Inducers Using a Cell- and Caspase-based High-Throughput Screening Assay. 1. Structure−Activity Relationships of the 4-Aryl Group

William Kemnitzer, John Drewe, Songchun Jiang et al. · Journal of Medicinal Chemistry · 2004 · 278 citations

Pilot phase l-ll study on 5-aza-2??-deoxycytidine (Decitabine) in patients with metastatic lung cancer

Richard L. Momparler, David Y. Bouffard, Louise F. Momparler et al. · Anti-Cancer Drugs · 1997 · 212 citations

Discovery and mechanism of action of a novel series of apoptosis inducers with potential vascular targeting activity

Shailaja Kasibhatla, Henriette Gourdeau, Karen Meerovitch et al. · Molecular Cancer Therapeutics · 2004 · 201 citations

Kinetic studies on 2',2'-difluorodeoxycytidine (gemcitabine) with purified human deoxycytidine kinase and cytidine deaminase

David Y. Bouffard, Josée Laliberté, Richard L. Momparler · Biochemical Pharmacology · 1993 · 186 citations

Medicinal Chemistry, Cytidine Deaminase, Biochemistry +4

Comparison of the induction of apoptosis in human leukemic cell lines by 2′,2′-difluorodeoxycytidine (gemcitabine) and cytosine arabinoside

David Y. Bouffard, Richard L. Momparler · Leukemia Research · 1995 · 48 citations

Hematological Malignancy, Cancer Research, Medicine +10